Home > Newsletters > International Pharmaceutical Regulatory Monitor > EMA to Wait for More Experience Before Issuing Guidance on Companion Diagnostics
International Pharmaceutical Regulatory Monitor
September 2012 | Vol. 40 No. 9
EMA to Wait for More Experience Before Issuing Guidance on Companion Diagnostics
Known for its relatively relaxed regulation of companion diagnostics (CDx), guidance from the European Medicines Agency (EMA) is not expected until the agency gains more experience with these drug-device combinations, an expert says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.